Review



nucleolin polyclonal antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Proteintech nucleolin polyclonal antibody
    Nucleolin Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 63 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nucleolin polyclonal antibody/product/Proteintech
    Average 94 stars, based on 63 article reviews
    nucleolin polyclonal antibody - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    94
    Developmental Studies Hybridoma Bank hybridoma against nucleolin
    Hybridoma Against Nucleolin, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hybridoma against nucleolin/product/Developmental Studies Hybridoma Bank
    Average 94 stars, based on 1 article reviews
    hybridoma against nucleolin - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    Proteintech nucleolin polyclonal antibody
    Nucleolin Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nucleolin polyclonal antibody/product/Proteintech
    Average 94 stars, based on 1 article reviews
    nucleolin polyclonal antibody - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    Proteintech nucleolin antibody
    Nucleolin Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nucleolin antibody/product/Proteintech
    Average 94 stars, based on 1 article reviews
    nucleolin antibody - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    Proteintech nucleolin ncl
    Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and <t>nucleolin</t> expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, <t>NCL</t> and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
    Nucleolin Ncl, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nucleolin ncl/product/Proteintech
    Average 94 stars, based on 1 article reviews
    nucleolin ncl - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology anti-nucleolin mouse monoclonal antibody
    Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and <t>nucleolin</t> expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, <t>NCL</t> and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
    Anti Nucleolin Mouse Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-nucleolin mouse monoclonal antibody/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    anti-nucleolin mouse monoclonal antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc alexa fluor 488-labeled nucleolin monoclonal antibody
    Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and <t>nucleolin</t> expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, <t>NCL</t> and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
    Alexa Fluor 488 Labeled Nucleolin Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alexa fluor 488-labeled nucleolin monoclonal antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    alexa fluor 488-labeled nucleolin monoclonal antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc nucleolin antibody 14574t
    Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and <t>nucleolin</t> expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, <t>NCL</t> and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
    Nucleolin Antibody 14574t, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nucleolin antibody 14574t/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    nucleolin antibody 14574t - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc alexa fluor® 488-labeled nucleolin monoclonal antibody
    Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and <t>nucleolin</t> expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, <t>NCL</t> and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
    Alexa Fluor® 488 Labeled Nucleolin Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alexa fluor® 488-labeled nucleolin monoclonal antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    alexa fluor® 488-labeled nucleolin monoclonal antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc anti ncl
    Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and <t>nucleolin</t> expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, <t>NCL</t> and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
    Anti Ncl, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti ncl/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    anti ncl - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    Image Search Results


    Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and nucleolin expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, NCL and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.

    Journal: World Journal of Hepatology

    Article Title: Chromatin accessibility module identified by single-cell sequencing underlies the diagnosis and prognosis of hepatocellular carcinoma

    doi: 10.4254/wjh.v17.i6.107329

    Figure Lengend Snippet: Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and nucleolin expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, NCL and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.

    Article Snippet: Gene expression of midkine (MDK) (1:1000; Proteintech #11009-1-AP) and nucleolin (NCL) (1:1000; Proteintech #83380-1-RR) was further identified in biological triplicates with statistical significance assessed by student’s t -test ( P < 0.05). siRNA transfection: siRNA was designed using the DharmaconTM siRNA Design Tool.

    Techniques: Transformation Assay, Protein-Protein interactions, Expressing, Western Blot, Transfection, Binding Assay, Control, RNA Sequencing